Ferat-Osorio Eduardo, Wong-Baeza Isabel, Esquivel-Callejas Noemí, Figueroa-Figueroa Silvia, Duarte-Rojo Andrés, Guzmán-Valdivia-Gómez Gilberto, Rodea-Rosas Heriberto, Torres-González Rubén, Sánchez-Fernández Patricio, Arriaga-Pizano Lourdes, López-Macías Constantino, Robles-Díaz Guillermo, Isibasi Armando
Medical Research Unit on Immunochemistry, Specialties Hospital, National Medical Centre Siglo XXI, Mexican Institute for Social Security, Mexico City, Mexico.
Crit Care. 2009;13(3):R69. doi: 10.1186/cc7876. Epub 2009 May 14.
Acute pancreatitis (AP) is usually a mild and self-limiting disease, but some patients develop a severe form that is associated with high mortality. In AP, local inflammation is followed first by the systemic inflammatory response syndrome and then by the compensatory anti-inflammatory response syndrome, which is defined by low human leukocyte antigen (HLA)-DR expression on monocytes, increased concentration of the anti-inflammatory cytokine IL-10, and decreased monocyte function. Our aim was to measure the expression of triggering receptor expressed on myeloid cells (TREM)-1 (a proposed marker of infection or inflammation) and HLA-DR on monocytes, and the serum concentrations of IL-6 (a proinflammatory cytokine) and IL-10 in patients with AP to determine whether these markers can identify patients at high risk of developing severe AP or infection.
Fifty healthy volunteers, 18 patients with mild AP, and 11 patients with severe AP were included in this study. Samples were taken at admission and one and three days later. TREM-1 and HLA-DR expression was evaluated by flow cytometry, and soluble TREM-1, IL-6 and IL-10 concentrations were measured by ELISA.
TREM-1 expression was higher in patients with AP than in healthy volunteers, but there was no difference between patients with mild and severe AP. TREM-1 expression was not associated with mortality or with the presence of infection. Soluble TREM-1 concentration in serum was higher in non-survivors than in survivors. HLA-DR expression was lower and IL-6 concentration higher in patients with severe AP and in infected patients.
Increased TREM-1 expression was associated with the presence of inflammation but not infection in AP. In patients with AP, low HLA-DR expression and high IL-6 concentration could predict severity and infection in samples taken shortly after admission.
急性胰腺炎(AP)通常是一种轻度的自限性疾病,但有些患者会发展为重症形式,其死亡率很高。在急性胰腺炎中,局部炎症首先会引发全身炎症反应综合征,随后是代偿性抗炎反应综合征,后者的定义为单核细胞上人类白细胞抗原(HLA)-DR表达降低、抗炎细胞因子白细胞介素-10(IL-10)浓度升高以及单核细胞功能下降。我们的目的是测量髓系细胞触发受体(TREM)-1(一种推测的感染或炎症标志物)在单核细胞上的表达以及HLA-DR的表达,同时测量急性胰腺炎患者血清中促炎细胞因子IL-6和IL-10的浓度,以确定这些标志物是否能够识别出有发展为重症急性胰腺炎或感染高风险的患者。
本研究纳入了50名健康志愿者、18名轻症急性胰腺炎患者和11名重症急性胰腺炎患者。在入院时以及入院后1天和3天采集样本。通过流式细胞术评估TREM-1和HLA-DR的表达,通过酶联免疫吸附测定法(ELISA)测量可溶性TREM-1、IL-6和IL-10的浓度。
急性胰腺炎患者的TREM-1表达高于健康志愿者,但轻症和重症急性胰腺炎患者之间没有差异。TREM-1表达与死亡率或感染的存在无关。非存活者血清中的可溶性TREM-1浓度高于存活者。重症急性胰腺炎患者和感染患者的HLA-DR表达较低,IL-6浓度较高。
TREM-1表达增加与急性胰腺炎中的炎症存在相关,但与感染无关。在急性胰腺炎患者中,入院后不久采集的样本中HLA-DR低表达和IL-6高浓度可预测病情严重程度和感染情况。